These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22344774)

  • 1. Calciphylaxis in CKD and beyond.
    Brandenburg VM; Kramann R; Specht P; Ketteler M
    Nephrol Dial Transplant; 2012 Apr; 27(4):1314-8. PubMed ID: 22344774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calciphylaxis in end-stage renal disease patients.
    Verdalles U; García de Vinuesa S; Luño J
    Nephrol Dial Transplant; 2012 Sep; 27(9):3663; author reply 3663-4. PubMed ID: 22805222
    [No Abstract]   [Full Text] [Related]  

  • 4. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines.
    Eiser AR
    Am J Med; 2014 Apr; 127(4):253-4. PubMed ID: 24333618
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for calciphylaxis in Chinese hemodialysis patients: a matched case-control study.
    Liu Y; Zhang X; Xie X; Yang X; Liu H; Tang R; Liu B
    Ren Fail; 2021 Dec; 43(1):406-416. PubMed ID: 33641601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calciphylaxis: an uncertain pathogenesis and controversial treatment].
    Marrón B; Coronel F; López-Bran E; Barrientos A
    Nefrologia; 2001; 21(6):596-600. PubMed ID: 11881431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calciphylaxis in a cardiac patient without renal disease.
    Almafragi A; Vandorpe J; Dujardin K
    Acta Cardiol; 2009 Feb; 64(1):91-3. PubMed ID: 19317304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study.
    Dobry AS; Ko LN; St John J; Sloan JM; Nigwekar S; Kroshinsky D
    JAMA Dermatol; 2018 Feb; 154(2):182-187. PubMed ID: 29238798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin-induced pulmonary metastatic calcification and calciphylaxis in a patient with end-stage renal disease.
    Cadavid JC; DiVietro ML; Torres EA; Fumo P; Eiger G
    Chest; 2011 Jun; 139(6):1503-1506. PubMed ID: 21652561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous calciphylaxis in a haemodialysis patient.
    Paskalev D; Kircheva A
    J Wound Care; 2005 Jul; 14(7):312. PubMed ID: 16048216
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of Risk Factors for Calciphylaxis in Hemodialysis Patients in the Fraser Health Renal Program - A Matched Case-Control Retrospective Review.
    Jang A; Mark Ho MH; Yan L
    J Pharm Pract; 2023 Dec; 36(6):1424-1437. PubMed ID: 36036088
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe calciphylaxis in a renal patient on long-term oral anticoagulant therapy.
    Rudwaleit M; Schwarz A; Trautmann C; Offermann G; Distler A
    Am J Nephrol; 1996; 16(4):344-8. PubMed ID: 8739290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and outcomes of calciphylaxis in Chinese patients with chronic kidney disease.
    Jiao Y; Sun L; Xie X; Liu H; Zhao Y; Ni H; Zhang X
    Nephrology (Carlton); 2023 Jun; 28(6):305-314. PubMed ID: 36883928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin-induced calciphylaxis successfully treated with sodium thiosulphate.
    Hafiji J; Deegan P; Brais R; Norris P
    Australas J Dermatol; 2013 May; 54(2):133-5. PubMed ID: 23581997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis.
    Sulková SD; Válek M
    Nutrition; 2010 Sep; 26(9):910-4. PubMed ID: 20692603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciphylaxis: Beyond CKD-MBD.
    Fernández M; Morales E; Gutierrez E; Polanco N; Hernández E; Mérida E; Praga M
    Nefrologia; 2017; 37(5):501-507. PubMed ID: 28390776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciphylaxis in the patient with chronic renal failure.
    Hahler B
    Dermatol Nurs; 2001 Dec; 13(6):435-6, 449. PubMed ID: 11837181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and mortality associated with calciphylaxis in end-stage renal disease.
    Mazhar AR; Johnson RJ; Gillen D; Stivelman JC; Ryan MJ; Davis CL; Stehman-Breen CO
    Kidney Int; 2001 Jul; 60(1):324-32. PubMed ID: 11422768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases.
    Savoia F; Gaddoni G; Patrizi A; Misciali C; Odorici G; Tampieri G; Tampieri E; Cantelli S; Aldi M
    G Ital Dermatol Venereol; 2013 Oct; 148(5):531-6. PubMed ID: 24005147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calciphylaxis: case report and literature review.
    Somorin AO; Al Harbi A; Subaity Y; Zaman AU
    Afr J Med Med Sci; 2002 Jun; 31(2):175-8. PubMed ID: 12518918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.